ARTICLE | Finance
Family time
Why Dragonfly seeks family offices and strategic partners over traditional VCs
June 16, 2017 7:37 PM UTC
With funding from family offices and now a new deal with Celgene Corp. (NASDAQ:CELG), Dragonfly Therapeutics Inc. says it will not need traditional VC financing to bring its first cancer therapy into the clinic.
CEO Bill Haney told BioCentury Dragonfly prefers funding from family offices, especially those driven by a mission rather than an exit timeline. ...
BCIQ Company Profiles